Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in treponema pallidum in the United States, 2007 to 2009

Sexually Transmitted Diseases

Volumn 39, Issue 10, 2012, Pages 794-798

  Su, John R ^a   Pillay, Allan ^a   Hook, Edward W ^b   Ghanem, Khalil G ^c   Wong, William ^d   Jackson, Dawn ^e   Smith, Lewis D ^a,f   Pierce, Elaine ^g   Philip, Susan S ^h   Wilson, Steven ⁱ   Golden, Matthew R ^j   Workowski, Kimberly A ^a,k   Chi, Kai Hua ^a   Parrish, Deidra D ^l   Chen, Cheng Y ^a   Weinstock, Hillard S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHICAGO DEPARTMENT OF PUBLIC HEALTH   (United States)

^e Detroit Department of Health and Wellness Promotion   (United States)

^f NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^g UNIVERSITY OF CALIFORNIA COOPERATIVE EXTENSION   (United States)

^h SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

ⁱ Dallas County Health and Human Services   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k EMORY UNIVERSITY   (United States)

^l VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL DNA; DOXYCYCLINE; PENICILLIN DERIVATIVE; RNA 23S;

ADULT; ARTICLE; BACTERIAL STRAIN; DNA SEQUENCE; FEMALE; GENITAL ULCER; HUMAN; MALE; MALE HOMOSEXUAL; MOLECULAR TYPING; NONHUMAN; POINT MUTATION; PREVALENCE; SYPHILIS; TREPONEMA PALLIDUM; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; PENICILLIN G BENZATHINE; POINT MUTATION; PREVALENCE; RNA, RIBOSOMAL, 23S; SYPHILIS; TREPONEMA PALLIDUM; UNITED STATES; YOUNG ADULT;

EID: 84866680064     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31826f36de     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
2. Hook EW 3rd, Behets F, Van Damme K, et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis 2010; 201:1729-1735.
3. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005; 353:1236-1244. (Pubitemid 41345945)
4. Hook EW 3rd, Stephens J, Ennis DM. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann Intern Med 1999; 131:434-437. (Pubitemid 29444434)
5. Rekart M, Patrick D, Jolly A, et al. Mass treatment/prophylaxis during an outbreak of infectious syphilis in Vancouver, British Columbia. Can Commun Dis Rep 2000; 26:101-105.
6. Matejkova P, Flasarova M, Zakoucka H, et al. Macrolide treatment failure in a case of secondary syphilis: A novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. J Med Microbiol 2009; 58(pt 6):832-836.
7. Mitchell SJ, Engelman J, Kent CK, et al. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin Infect Dis 2006; 42:337-345. (Pubitemid 43122308)
8. Zhou P, Li K, Lu H, et al. Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai. Sex Transm Dis 2010; 37:726-729.
9. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351:154-158.
10. Stamm LV, Stapleton JT, Bassford PJ Jr. In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum. Antimicrob Agents Chemother 1988; 32: 164-169. (Pubitemid 18061368)
11. Stamm LV, Bergen HL. A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob Agents Chemother 2000; 44:806-807. (Pubitemid 30117989)
12. Martin IE, Tsang RS, Sutherland K, et al. Molecular characterization of syphilis in patients in Canada: Azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. J Clin Microbiol 2009; 47:1668-1673.
13. Martin IE, Gu W, Yang Y, et al. Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin Infect Dis 2009; 49:515-521.
14. Pillay A, Liu H, Chen CY, et al. Molecular subtyping of Treponema pallidum subspecies pallidum. Sex Transm Dis 1998; 25:408-414. (Pubitemid 28446748)
15. Pope V, Fox K, Liu H, et al. Molecular subtyping of Treponema pallidum from North and South Carolina. J Clin Microbiol 2005; 43: 3743-3746. (Pubitemid 41129654)
16. Chen CY, Chi KH, George RW, et al. Diagnosis of gastric syphilis by direct immunofluorescence staining and real-Time PCR testing. J Clin Microbiol 2006; 44:3452-3426.
17. Pandori MW, Gordones C, Castro L, et al. Detection of azithromycin resistance in Treponema pallidum by real-Time PCR. Antimicrob Agents Chemother. 2007; 51:3425-3430. (Pubitemid 350067571)
18. Katz KA, Pillay A, Ahrens K, et al. Molecular epidemiology of syphilisVSan Francisco, 2004-2007. Sex Transm Dis 2010; 37: 660-663.
19. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2009. Atlanta, GA: Department of Health and Human Services, 2010.
20. Centers for Disease Control and Prevention. Primary and secondary syphilisVJefferson county, Alabama, 2002-2007. MMWR Morb Mortal Wkly Rep 2009; 58:463-467.
21. Morshed MG, Jones HD. Treponema pallidum macrolide resistance in BC. CMAJ 2006; 174:349.
22. Corti M, Palmero D. Mycobacterium avium complex infection in HIV/AIDS patients. Expert Rev Anti Infect Ther 2008; 6:351-363.
23. Marra CM, Colina AP, Godornes C, et al. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J Infect Dis 2006; 194:1771-1773. (Pubitemid 44902010)
24. Marra CM, Sahi SK, Tantalo LC, et al. Enhanced molecular typing of Treponema pallidum: Geographical distribution of strain types and association with neurosyphilis. J Infect Dis 2010; 202: 1380-1388.
25. Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother 2010; 54:3812-3816.
26. Zhu H, Wang HP, Jiang Y, et al. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage. Andrologia 2010; 42:274-280.
27. Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 2004; 48:4624-4630. (Pubitemid 39577663)
28. Cole MJ, Chisholm SA, Palmer HM, et al. Molecular epidemiology of syphilis in Scotland. Sex Transm Infect 2009; 85:447-451.
29. Sutton MY, Liu H, Steiner B, et al. Molecular subtyping of Treponema pallidum in an Arizona County with increasing syphilis morbidity: Use of specimens from ulcers and blood. J Infect Dis 2001; 183:1601-1606. (Pubitemid 32466697)
30. Florindo C, Reigado V, Gomes JP, et al. Molecular typing of Treponema pallidum clinical strains from Lisbon, Portugal. J Clin Microbiol 2008; 46:3802-3803.
31. Azzato F, Ryan N, Fyfe J, et al. Molecular subtyping of Treponema pallidum during a local syphilis epidemic in men who have sex with men in Melbourne, Australia. J Clin Microbiol 2012; 50:1895-1899.
32. Heffelfinger JD, Swint EB, Berman SM, et al. Trends in primary and secondary syphilis among men who have sex with men in the United States. Am J Public Health 2007; 97:1076-1083. (Pubitemid 351181931)
33. Peterman TA, Heffelfinger JD, Swint EB, et al. The changing epidemiology of syphilis. Sex Transm Dis 2005; 32(suppl 10):S4-S10. (Pubitemid 41429166)